Enzyme Replacement Therapy Medicines
What the buyer wrote
Supply of Enzyme Replacement Therapy Medicines (a-d) to NHS Scotland: - NP92624(a) Laronidase 500units/5ml solution for infusion vials 1 vial (Aldurazyme®) - NP92624(b) Imiglucerase 400unit powder for solution for infusion vials 1 vial (Cerezyme®) - NP92624(c) Agalsidase beta 35mg powder for solution for infusion vials 1 vial (Fabrazyme®) - NP92624(c) Agalsidase beta 5mg powder for solution for infusion vials 1 vial (Fabrazyme®) - NP92624(d) Alglucosidase alfa 50mg powder for solution for infusion vials 1 vial (Myozyme®)
Bid for this and lost? There is a short window in which the decision can be questioned.
Details
- What the buyer calls it
- Enzyme Replacement Therapy Medicines
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- goods
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Where
- in Scotland
- Kind of work
- Pharmacy and medicines
Who the buyer named
The buyer published a contact address on this notice.